1. Home
  2. Browse
  3. Practice
  4. Legal & Licensing
  5. Drug Withdrawals/Restricted Sale

Drug Withdrawals/Restricted Sale

106 - 120 of 152 Results
Sort Results:
Article: Genentech is pulling Raptiva (efalizumab) from the market due to the risk of an opportunistic brain infection called PML May 2009
Other: FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market May 2009
Article: concerns about opioid shortages May 2009
Commentary: FDA to Halt Marketing of Certain Unapproved Prescription Opioids May 2009
Article: Metoclopramide will have a new black box warning about the risk for tardive dyskinesia April 2009
Article: greater scrutiny of propoxyphene (Darvocet, Darvon, etc) March 2009
Commentary: Propoxyphene: Safety and Efficacy March 2009
Article: OTC Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the ma February 2009
Article: Instant cold packs are now being used to make methamphetamine February 2009
Commentary: Phase-out of Epinephrine CFC Metered-Dose Inhalers February 2009
Commentary: Phase-out of Epinephrine CFC Metered-Dose Inhalers: Questions and Answers February 2009
Article: Patients are hearing that they might be getting unapproved medications from doctors and pharmacies January 2009
Article: Stronger warnings about kidney problems are leading to a recall of Fleet Phospho-soda and some other oral sodium phosphate solutions January 2009
Article: Buprenorphine tablets (Subutex, Suboxone) are now being used more for treating PAIN January 2009
Commentary: Suboxone/Subutex for Pain January 2009